- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Bio-Rad Laboratories Inc
+ Add to WatchlistBIO:US
115.2101 USD 0.3599 0.31%As of 13:54:58 ET on 05/24/2013.
Snapshot for Bio-Rad Laboratories Inc (BIO)
| Open: | 114.1000 | Day's Range: | 114.0000 - 115.5300 | Volume: | 17,595 |
|---|---|---|---|---|---|
| Previous Close: | 115.5700 | 52wk Range: | 91.5200 - 127.1700 | 1-Yr Rtn: | +12.93% |
Key Statistics for BIO
| Current P/E Ratio (ttm) | 21.9234 |
|---|---|
| Estimated P/E(12/2013) | 23.3395 |
| Relative P/E vs. SPX | 1.3703 |
| Earnings Per Share (USD) (ttm) | 5.2186 |
| Est. EPS (USD) (12/2013) | 4.9020 |
| Est. PEG Ratio | 1.6096 |
| Market Cap (M USD) | 3,265.71 |
| Shares Outstanding (M) | 23.44 |
| 30 Day Average Volume | 93,194 |
| Price/Book (mrq) | 1.6180 |
| Price/Sale (ttm) | 1.5690 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BIO
Company Profile & Key Executives for BIO
Bio-Rad Laboratories, Inc. is a multinational manufacturer and distributor of life science research products, clinical diagnostics, and analytical instrumentation. The Company's products and systems separate complex chemical and biological materials, as well as identify, analyze, and purify their components.
| Norman SchwartzChairman/President/CEO | Christine A TsingosVP/CFO |
| Ronald W HuttonVP/Treasurer | Bradford J CrutchfieldExec VP/Pres:Life Science |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BIO News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page